Georgios Yiannopoulos

Experience with rituximab in scleroderma: results from a 1-year, proof-of-principle study

Dimitrios Daoussis, Stamatis‐Nick C. Liossis, Athanassios C. Tsamandas et al. · Lara D. Veeken · 2009 · 392 citations · Full text

Medicine, Immunology, Pharmacotherapy +13

Evidence that Dkk‐1 is dysfunctional in ankylosing spondylitis

Dimitrios Daoussis, Stamatis‐Nick C. Liossis, Elena E. Solomou et al. · Arthritis & Rheumatism · 2009 · 233 citations

Medicine, Clinical Sciences, Immunology +17

Effect of long-term treatment with rituximab on pulmonary function and skin fibrosis in patients with diffuse systemic sclerosis.

Dimitrios Daoussis, Stamatis‐Nick C. Liossis, Athanassios C. Tsamandas et al. · PubMed · 2012 · 184 citations

Medicine, Clinical Sciences, Pharmacotherapy +16

ACTH as first line treatment for acute gout in 181 hospitalized patients

Dimitrios Daoussis, Ioannis Antonopoulos, Georgios Yiannopoulos et al. · Joint Bone Spine · 2012 · 41 citations

Health Professions, Hospital Pharmacy, Hospital Medicine +5

B-Cell Depletion Therapy in Systemic Sclerosis: Experimental Rationale and Update on Clinical Evidence

Dimitrios Daoussis, Stamatis‐Nick C. Liossis, Georgios Yiannopoulos et al. · International Journal of Rheumatology · 2011 · 37 citations · Full text

Medicine, Immunology, Pharmacotherapy +17